| Stage | UTI | % of rev | LAUR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $219M | 100.00% | $485M | 100.00% | LAUR ×2.22 |
| Gross profit | $219M | 100.00% | $132M | 27.15% | UTI +72.9pp |
| Operating income | $3M | 1.48% | $119M | 24.56% | LAUR +23.1pp |
| Pre-tax income | $3M | 1.42% | $121M | 24.99% | LAUR +23.6pp |
| Net income | $2M | 1.04% | $101M | 20.87% | LAUR +19.8pp |
| Stage | UTI | LAUR | Gap · A − B |
|---|---|---|---|
| Revenue | $219M100.00% | $485M100.00% | LAUR ×2.22 |
| Gross profit | 100.00%$219M | 27.15%$132M | UTI +72.9pp |
| Operating income | 1.48%$3M | 24.56%$119M | LAUR +23.1pp |
| Pre-tax income | 1.42%$3M | 24.99%$121M | LAUR +23.6pp |
| Net income |
| 1.04%$2M |
| 20.87%$101M |
| LAUR +19.8pp |
No disclosed counterparties: LAUR.
None